- Home
- EVAX vs CMND Comparison
EVAX vs CMND Comparison
Compare EVAX & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- CMND
- Stock Information
- Founded
- EVAX 2008
- CMND 2017
- Country
- EVAX Denmark
- CMND Canada
- Employees
- EVAX N/A
- CMND N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- EVAX Health Care
- CMND Health Care
- Exchange
- EVAX Nasdaq
- CMND Nasdaq
- Market Cap
- EVAX 17.8M
- CMND 5.3M
- IPO Year
- EVAX 2021
- CMND N/A
- Fundamental
- Price
- EVAX $2.90
- CMND $1.03
- Analyst Decision
- EVAX Strong Buy
- CMND
- Analyst Count
- EVAX 2
- CMND 0
- Target Price
- EVAX $10.00
- CMND N/A
- AVG Volume (30 Days)
- EVAX 89.0K
- CMND 36.6K
- Earning Date
- EVAX 10-30-2025
- CMND 09-11-2025
- Dividend Yield
- EVAX N/A
- CMND N/A
- EPS Growth
- EVAX N/A
- CMND N/A
- EPS
- EVAX N/A
- CMND N/A
- Revenue
- EVAX $3,176,000.00
- CMND N/A
- Revenue This Year
- EVAX N/A
- CMND N/A
- Revenue Next Year
- EVAX N/A
- CMND N/A
- P/E Ratio
- EVAX N/A
- CMND N/A
- Revenue Growth
- EVAX 1042.45
- CMND N/A
- 52 Week Low
- EVAX $1.20
- CMND $0.80
- 52 Week High
- EVAX $17.20
- CMND $2.18
- Technical
- Relative Strength Index (RSI)
- EVAX 50.88
- CMND 51.58
- Support Level
- EVAX $2.71
- CMND $0.99
- Resistance Level
- EVAX $3.04
- CMND $1.07
- Average True Range (ATR)
- EVAX 0.20
- CMND 0.04
- MACD
- EVAX -0.01
- CMND -0.00
- Stochastic Oscillator
- EVAX 55.97
- CMND 40.56
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.